Fieldpoint Private Securities, LLC Ascendis Pharma A/S Transaction History

Fieldpoint Private Securities, LLC

  • $344 Million
  • Q2 2022

A detailed history of Fieldpoint Private Securities, LLC transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Fieldpoint Private Securities, LLC holds 10 shares of ASND stock, worth $1,446. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10
Previous 20 50.0%
Holding current value
$1,446
Previous $2,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 05, 2022
SELL
$78.08 - $117.61 $780 - $1,176
-10 Reduced 50.0%
10 $1,000
Q4 2020

Jan 28, 2021
BUY
$151.2 - $182.76 $3,024 - $3,655
20 New
20 $3,000

Others Institutions Holding ASND

# of Institutions
223
Shares Held
56.5M
Call Options Held
142K
Put Options Held
259K
View Full List

About Ascendis Pharma A/S

ASND Quotes by TradingView
  • Ticker ASND
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,810,200
  • Market Cap $8.07B
  • Description
  • Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...
More about ASND
Track This Portfolio

Track Fieldpoint Private Securities, LLC Portfolio

Follow Fieldpoint Private Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fieldpoint Private Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fieldpoint Private Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email